Potential Relief for Knee Pain

Knee problems aren’t just a concern for older individuals; many younger people are facing significant knee pain and increasingly looking towards surgical solutions.

However, a new treatment could be on the horizon that helps alleviate joint inflammation, pain, and the stiffness that often accompany arthritis and various knee injuries.

Most people will eventually experience some degree of wear on the cartilage that protects the ends of their bones. This can develop into osteoarthritis with age or be triggered by injuries like ACL tears, commonly caused by activities involving pivoting, jumping, or sudden stops.

Typically, the solution for severe arthritis is joint replacement surgery, which can be quite expensive and may not even be necessary for the millions who suffer from the condition.

Researchers at Stanford Medicine have made a significant discovery through studies conducted on older mice. They found a groundbreaking treatment that regenerates damaged knee cartilage by restoring lost cartilage and can potentially prevent osteoarthritis following knee injuries.

This innovative approach led to the development of new, functional joint cartilage. It all stems from further examination of a naturally occurring protein that becomes more prevalent with age.

The protein, known as 15-PGDH, has been identified as a “gerozyme”—an enzyme linked to the gradual decline in tissue function as we age.

By inhibiting this protein in older mice, researchers observed an increase in muscle mass and endurance, alongside the regeneration of bone, nerve, and blood cells.

Interestingly, cartilage doesn’t heal through stem cells; rather, it adapts by altering its gene expression patterns instead.

According to senior study author Helen Blau, this represents a novel approach for regenerating adult tissue, potentially transforming treatments for arthritis induced by aging or injury.

Her colleague, Nidhi Bhutani, added that the gerozyme inhibitor prompts extensive cartilage regeneration, exceeding effects seen from any other drugs or treatments so far.

Building on prior research, the same team identified a key molecule, prostaglandin E2, essential for muscle stem cell function, which 15-PGDH breaks down. When this protein is blocked, levels of prostaglandin E2 rise, assisting in the healing of damaged muscle, nerve, bone, liver, and blood cells in younger mice.

When older mice received injections of a small molecule designed to inhibit 15-PGDH, their knee cartilage became substantially thicker. It was also noteworthy that these cells were generating hyaline cartilage, which is crucial for smooth joint movement. Bhutani mentioned that the extent of cartilage regeneration was quite surprising and “the effects were remarkable.”

The team also explored if this inhibitor could aid recovery after a severe knee injury. Approximately half of those who endure such injuries may go on to develop osteoarthritis.

The mice treated with the 15-PGDH inhibitor twice weekly over four weeks demonstrated a decreased likelihood of developing arthritis, in contrast to untreated counterparts that did develop it within the same timeframe.

In essence, this treatment seems to encourage cartilage to revert to a younger biological state without needing stem cells.

Further analysis of cartilage samples from osteoarthritis patients treated with the inhibitor showed promise: after just one week, there was a reduction in 15-PGDH proteins, a decline in cartilage degradation, along with signs of cartilage regeneration.

The research team’s insights into tissue healing and regrowth have evolved, suggesting that existing cells in cartilage are altering their gene expression in a significant way. Bhutani noted that targeting these cells for regeneration could lead to a more profound clinical impact.

Although these findings are currently based on mouse models, there is an oral version of the 15-PGDH inhibitor used for age-related muscle weakness that has shown safety in humans. Further clinical trials will be necessary to verify the safety and efficacy specifically for cartilage regeneration.